The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: GlaxoWellcome
Approval Status: Approved September 1997
Treatment for: acute bronchitis
General Information
Ceftin (Cefuroxime axetil) has been approved by the U.S. Food and Drug Administration for the treatment of secondary bacterial infections of acute bronchitis with 5-day therapy.